S. Gordon, Alternative activation of macrophages, Nature Reviews Immunology, vol.3, issue.1, pp.23-35, 2003.
DOI : 10.1038/nri978

URL : https://hal.archives-ouvertes.fr/hal-00474829

O. Garra, A. Arai, and N. , The molecular basis of T helper 1 and T helper 2 cell differentiation, Trends Cell Biol, vol.10, pp.542-550, 2000.

M. Colonna, Can we apply the TH1-TH2 paradigm to all lymphocytes?, Nature Immunology, vol.183, issue.10, pp.899-900, 2001.
DOI : 10.1038/ni1001-899

W. Gong, O. Howard, J. Turpin, M. Grimm, H. Ueda et al., Monocyte Chemotactic Protein-2 Activates CCR5 and Blocks CD4/CCR5-mediated HIV-1 Entry/Replication, Journal of Biological Chemistry, vol.273, issue.8, pp.4289-4292, 1998.
DOI : 10.1074/jbc.273.8.4289

M. Truong, E. Darcissac, E. Hermann, J. Dewulf, A. Capron et al., Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells, J Virol, vol.73, pp.7008-7013, 1999.

J. Kutza, M. Hayes, and K. Clouse, Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5, AIDS, vol.12, issue.8, pp.59-64, 1998.
DOI : 10.1097/00002030-199808000-00001

A. Rodriguez, B. Arulanandam, V. Hodara, H. Mcclure, E. Cobb et al., Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees, Journal of General Virology, vol.88, issue.2, pp.641-651, 2007.
DOI : 10.1099/vir.0.82154-0

A. Biancotto, J. Grivel, S. Iglehart, C. Vanpouille, A. Lisco et al., Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood, pp.4272-4279, 2007.

T. Fehniger, G. Herbein, H. Yu, M. Para, Z. Bernstein et al., Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection, J Immunol, vol.161, pp.6433-6438, 1998.

R. Ahmad, S. Sindhu, T. E. Morisset, R. Ahmad, and A. , Elevated Levels of Circulating Interleukin-18 in Human Immunodeficiency Virus-Infected Individuals: Role of Peripheral Blood Mononuclear Cells and Implications for AIDS Pathogenesis, Journal of Virology, vol.76, issue.24, pp.12448-12456, 2002.
DOI : 10.1128/JVI.76.24.12448-12456.2002

D. Torre and A. Pugliese, Interleukin-18: A Proinflammatory Cytokine in HIV-1 Infection, Current HIV Research, vol.4, issue.4, pp.423-430, 2006.
DOI : 10.2174/157016206778559993

H. Choi, C. Dinarello, and L. Shapiro, Interleukin???18 Inhibits Human Immunodeficiency Virus Type 1 Production in Peripheral Blood Mononuclear Cells, The Journal of Infectious Diseases, vol.184, issue.5, pp.560-568, 2001.
DOI : 10.1086/322805

P. Di-marzio, R. Mariani, R. Lui, E. Thomas, and N. Landau, SOLUBLE CD40 LIGAND INDUCES ??-CHEMOKINE PRODUCTION BY MACROPHAGES AND RESISTANCE TO HIV-1 ENTRY, Cytokine, vol.12, issue.10, pp.1489-1495, 2000.
DOI : 10.1006/cyto.1999.0594

R. Kornbluth, The emerging role of CD40 ligand in HIV infection, J Leukoc Biol, vol.68, pp.373-382, 2000.

R. Kornbluth, K. Kee, and D. Richman, CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines, Proc Natl Acad Sci, vol.95, pp.40-5205, 1998.

N. Tedla, P. Palladinetti, M. Kelly, R. Kumar, N. Digirolamo et al., Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection, Am J Pathol, vol.148, pp.1367-1373, 1996.

M. Alfano, H. Schmidtmayerova, C. Amella, T. Pushkarsky, and M. Bukrinsky, The B-Oligomer of Pertussis Toxin Deactivates Cc Chemokine Receptor 5 and Blocks Entry of M-Tropic HIV-1 Strains, The Journal of Experimental Medicine, vol.142, issue.5, pp.597-605, 1999.
DOI : 10.1084/jem.164.1.280

G. Zybarth, N. Reiling, H. Schmidtmayerova, B. Sherry, and M. Bukrinsky, Activationinduced resistance of human macrophages to HIV-1 infection in vitro, J Immunol, vol.162, pp.400-406, 1999.

C. Palmieri, F. Trimboli, A. Puca, G. Fiume, G. Scala et al., Inhibition of HIV- 1 replication in primary human monocytes by the IkappaB-alphaS32/ 36A repressor of NF-kappaB, Retrovirology, vol.1, issue.1, p.45, 2004.
DOI : 10.1186/1742-4690-1-45

E. Duh, W. Maury, T. Folks, A. Fauci, and A. Rabson, Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat., Proceedings of the National Academy of Sciences, vol.86, issue.15, pp.5974-5978, 1989.
DOI : 10.1073/pnas.86.15.5974

L. Osborn, S. Kunkel, and G. Nabel, Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B., Proceedings of the National Academy of Sciences, vol.86, issue.7, pp.2336-2340, 1989.
DOI : 10.1073/pnas.86.7.2336

G. Poli, P. Bressler, A. Kinter, E. Duh, W. Timmer et al., Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms, Journal of Experimental Medicine, vol.172, issue.1, pp.151-158, 1990.
DOI : 10.1084/jem.172.1.151

S. Butera, B. Roberts, K. Leung, G. Nabel, and T. Folks, Tumor necrosis factor receptor expression and signal transduction in HIV-I-infected cells, AIDS, vol.7, issue.7, pp.911-918, 1993.
DOI : 10.1097/00002030-199307000-00002

G. Poli, A. Kinter, and A. Fauci, Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist., Proceedings of the National Academy of Sciences, vol.91, issue.1, pp.108-112, 1994.
DOI : 10.1073/pnas.91.1.108

M. Ruocco, X. Chen, C. Ambrosino, E. Dragonetti, W. Liu et al., Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NFkappaB/Rel transcription factors, J Biol Chem, vol.271, pp.22479-22486, 1996.

V. Tesmer, A. Rajadhyaksha, J. Babin, and M. Bina, NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1., Proceedings of the National Academy of Sciences, vol.90, issue.15, pp.7298-7302, 1993.
DOI : 10.1073/pnas.90.15.7298

Y. Yang, V. Tesmer, and M. Bina, Regulation of HIV-1 Transcription in Activated Monocyte Macrophages, Virology, vol.299, issue.2, pp.256-265, 2002.
DOI : 10.1006/viro.2001.1530

E. Lee, H. Zhou, and A. Henderson, Endothelial Cells Enhance Human Immunodeficiency Virus Type 1 Replication in Macrophages through a C/EBP-Dependent Mechanism, Journal of Virology, vol.75, issue.20, pp.9703-9712, 2001.
DOI : 10.1128/JVI.75.20.9703-9712.2001

T. Folks, J. Justement, A. Kinter, C. Dinarello, and A. Fauci, Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line, Science, vol.238, issue.4828, pp.800-802, 1987.
DOI : 10.1126/science.3313729

Y. Koyanagi, O. Brien, W. Zhao, J. Golde, D. Gasson et al., Cytokines alter production of HIV-1 from primary mononuclear phagocytes, Science, vol.241, issue.4873, pp.1673-1675, 1988.
DOI : 10.1126/science.3047875

A. Pugliese, V. Vidotto, T. Beltramo, and T. D. , Regulation of interleukin-18 by THP-1 monocytoid cells stimulated with HIV-1 and Nef viral protein, Eur Cytokine Netw, vol.16, pp.186-190, 2005.

L. Shapiro, A. Puren, H. Barton, D. Novick, R. Peskind et al., Interleukin 18 stimulates HIV type 1 in monocytic cells, Proceedings of the National Academy of Sciences, vol.95, issue.21, pp.12550-12555, 1998.
DOI : 10.1073/pnas.95.21.12550

S. Zurawski, F. Vega, . Jr, B. Huyghe, and G. Zurawski, Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction, EMBO J, vol.12, pp.2663-2670, 1993.

C. Hsieh, A. Heimberger, J. Gold, O. Garra, A. Murphy et al., Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6065-6069, 1992.
DOI : 10.1073/pnas.89.13.6065

R. Seder, W. Paul, M. Davis, and B. Fazekas-de-st-groth, The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice, Journal of Experimental Medicine, vol.176, issue.4, pp.1091-1098, 1992.
DOI : 10.1084/jem.176.4.1091

R. Coffman, J. Ohara, M. Bond, J. Carty, A. Zlotnik et al., Bc e l l stimulatory factor-1 enhances the IgE response of lipopolysaccharideactivated B cells, J Immunol, vol.136, pp.4538-4541, 1986.

H. Gascan, J. Gauchat, M. Roncarolo, H. Yssel, H. Spits et al., Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones, Journal of Experimental Medicine, vol.173, issue.3, pp.747-750, 1991.
DOI : 10.1084/jem.173.3.747

E. Vitetta, J. Ohara, C. Myers, J. Layton, P. Krammer et al., Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1, Journal of Experimental Medicine, vol.162, issue.5, pp.1726-1731, 1985.
DOI : 10.1084/jem.162.5.1726

A. Varin and S. Gordon, Alternative activation of macrophages: Immune function and cellular biology, Immunobiology, vol.214, issue.7, pp.630-671, 2009.
DOI : 10.1016/j.imbio.2008.11.009

R. De-waal-malefyt, C. Figdor, R. Huijbens, S. Mohan-peterson, B. Bennett et al., Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL- 10, J Immunol, vol.151, pp.6370-6381, 1993.

L. Montaner, A. Doyle, C. M. Herbein, G. Illei, P. James et al., Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro, Journal of Experimental Medicine, vol.178, issue.2, pp.743-747, 1993.
DOI : 10.1084/jem.178.2.743

G. Zurawski and J. De-vries, Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells, Immunology Today, vol.15, issue.1, pp.19-26, 1994.
DOI : 10.1016/0167-5699(94)90021-3

A. Mantovani, M. Locati, A. Vecchi, S. Sozzani, and P. Allavena, Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines, Trends in Immunology, vol.22, issue.6, pp.328-336, 2001.
DOI : 10.1016/S1471-4906(01)01941-X

M. Fenton, J. Buras, and R. Donnelly, IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes, J Immunol, vol.149, pp.1283-1288, 1992.

J. Wang, E. Guan, G. Roderiquez, V. Calvert, R. Alvarez et al., Role of Tyrosine Phosphorylation in Ligand-independent Sequestration of CXCR4 in Human Primary Monocytes-Macrophages, Journal of Biological Chemistry, vol.276, issue.52, pp.49236-49243, 2001.
DOI : 10.1074/jbc.M108523200

M. Mougel, L. Houzet, and J. Darlix, When is it time for reverse transcription to start and go? Retrovirology, p.24, 2009.

M. Denis and E. Ghadirian, Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1, AIDS Res Hum Retroviruses, vol.10, pp.795-802, 1994.

W. Hatch, A. Freedman, D. Boldt-houle, J. Groopman, and E. Terwilliger, Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages, pp.3443-3450, 1997.

L. Montaner, R. Bailer, and S. Gordon, IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity, J Leukoc Biol, vol.62, pp.126-132, 1997.

J. Mikovits, A. Meyers, J. Ortaldo, A. Minty, D. Caput et al., IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes, J Leukoc Biol, vol.56, pp.340-346, 1994.

H. Naif, S. Li, M. Ho-shon, J. Mathijs, P. Williamson et al., The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication, J Immunol, vol.158, pp.501-511, 1997.

H. Naif, M. Ho-shon, J. Chang, and A. Cunningham, Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes, J Leukoc Biol, vol.56, pp.335-339, 1994.

N. Kobayashi, Y. Hamamoto, Y. Koyanagi, I. Chen, and N. Yamamoto, Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression, Biochemical and Biophysical Research Communications, vol.165, issue.2, pp.715-721, 1989.
DOI : 10.1016/S0006-291X(89)80025-7

T. Okamoto, T. Matsuyama, S. Mori, Y. Hamamoto, N. Kobayashi et al., Augmentation of Human Immunodeficiency Virus Type 1 Gene Expression by Tumor Necrosis Factor ??, AIDS Research and Human Retroviruses, vol.5, issue.2, pp.131-138, 1989.
DOI : 10.1089/aid.1989.5.131

W. Farrar, M. Korner, and K. Clouse, Cytokine regulation of human immunodeficiency virus expression, Cytokine, vol.3, issue.6, pp.531-542, 1991.
DOI : 10.1016/1043-4666(91)90479-W

G. Poli and A. Fauci, The Role of Monocyte/Macrophages and Cytokines in the Pathogenesis of HIV Infection, Pathobiology, vol.60, issue.4, pp.246-251, 1992.
DOI : 10.1159/000163729

C. Gregory and A. Devitt, The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?, Immunology, vol.157, issue.1, pp.1-14, 2004.
DOI : 10.1182/blood-2003-09-3245

V. Fadok, D. Bratton, A. Konowal, P. Freed, J. Westcott et al., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF., Journal of Clinical Investigation, vol.101, issue.4, pp.890-898, 1998.
DOI : 10.1172/JCI1112

I. Tassiulas, K. Park-min, Y. Hu, L. Kellerman, D. Mevorach et al., Apoptotic Cells Inhibit LPS-Induced Cytokine and Chemokine Production and IFN Responses in Macrophages, Human Immunology, vol.68, issue.3, pp.156-164, 2007.
DOI : 10.1016/j.humimm.2006.12.008

E. Chung, S. Kim, and X. Ma, Regulation of cytokine production during phagocytosis of apoptotic cells, Cell Research, vol.165, issue.2, pp.154-161, 2006.
DOI : 10.1146/annurev.immunol.19.1.683

M. Alfano, A. Crotti, E. Vicenzi, and G. Poli, New players in cytokine control of HIV infection, Current HIV/AIDS Reports, vol.109, issue.1, pp.27-32, 2008.
DOI : 10.1007/s11904-008-0005-5

S. Sozzani, S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti et al., Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes, The Journal of Experimental Medicine, vol.83, issue.3, pp.439-444, 1998.
DOI : 10.1038/nm0397-338

J. Kutza, L. Crim, S. Feldman, M. Hayes, M. Gruber et al., Macrophage Colony-Stimulating Factor Antagonists Inhibit Replication of HIV-1 in Human Macrophages, The Journal of Immunology, vol.164, issue.9, pp.4955-4960, 2000.
DOI : 10.4049/jimmunol.164.9.4955

L. Montaner, P. Griffin, and S. Gordon, Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro, Journal of General Virology, vol.75, issue.12, pp.3393-3400, 1994.
DOI : 10.1099/0022-1317-75-12-3393

M. Saville, K. Taga, A. Foli, S. Broder, G. Tosato et al., Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage, Blood, vol.83, pp.3591-3599, 1994.

R. Akridge, L. Oyafuso, and S. Reed, IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages, J Immunol, vol.153, pp.5782-5789, 1994.

G. Poli, A. Kinter, J. Justement, P. Bressler, J. Kehrl et al., Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage, Journal of Experimental Medicine, vol.173, issue.3, pp.589-597, 1991.
DOI : 10.1084/jem.173.3.589

M. Malim, Natural resistance to HIV infection: The Vif???APOBEC interaction, Comptes Rendus Biologies, vol.329, issue.11, pp.871-875, 2006.
DOI : 10.1016/j.crvi.2006.01.012

R. Goila-gaur and K. Strebel, HIV-1 Vif, APOBEC, and Intrinsic Immunity, Retrovirology, vol.5, issue.1, p.51, 2008.
DOI : 10.1186/1742-4690-5-51

URL : http://doi.org/10.1186/1742-4690-5-51

R. Franca, S. Spadari, and G. Maga, APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism, Med Sci Monit, vol.12, pp.92-98, 2006.

S. Pillai, J. Wong, and J. Barbour, Turning up the volume on mutational pressure: is more of a good thing always better?

L. Carthagena, A. Bergamaschi, J. Luna, A. David, P. Uchil et al., Human TRIM Gene Expression in Response to Interferons, PLoS ONE, vol.18, issue.3, p.4894, 2009.
DOI : 10.1371/journal.pone.0004894.s001

R. Rajsbaum, J. Stoye, and O. Garra, Type???I interferon-dependent and -independent expression of tripartite motif proteins in immune cells, European Journal of Immunology, vol.102, issue.3, pp.619-630, 2008.
DOI : 10.1002/eji.200737916

G. Towers, The control of viral infection by tripartite motif proteins and cyclophilin A, Retrovirology, vol.4, issue.1, p.40, 2007.
DOI : 10.1186/1742-4690-4-40

H. Huthoff and G. Towers, Restriction of retroviral replication by APOBEC3G/F and TRIM5??, Trends in Microbiology, vol.16, issue.12, pp.612-619, 2008.
DOI : 10.1016/j.tim.2008.08.013

K. Bishop, M. Verma, E. Kim, S. Wolinsky, and M. Malim, APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts, PLoS Pathogens, vol.46, issue.12, p.1000231, 2008.
DOI : 10.1371/journal.ppat.1000231.s001

L. Carthagena, M. Parise, M. Ringeard, M. Chelbi-alix, U. Hazan et al., Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities, Retrovirology, vol.5, issue.1, p.59, 2008.
DOI : 10.1186/1742-4690-5-59

D. Weissman, G. Poli, and A. Fauci, Interleukin 10 Blocks HIV Replication in Macrophages by Inhibiting the Autocrine Loop of Tumor Necrosis Factor ?? and Interleukin 6 Induction of Virus, AIDS Research and Human Retroviruses, vol.10, issue.10, pp.1199-1206, 1994.
DOI : 10.1089/aid.1994.10.1199

D. Weissman, G. Poli, and A. Fauci, IL-10 Synergizes with Multiple Cytokines in Enhancing HIV Production in Cells of Monocytic Lineage, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.9, issue.5, pp.442-449, 1995.
DOI : 10.1097/00042560-199509050-00002

N. Kootstra, A. Van-'t-wout, H. Huisman, F. Miedema, and H. Schuitemaker, Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages, J Virol, vol.68, pp.6967-6975, 1994.

J. Yamamoto, F. Barre-sinoussi, V. Bolton, N. Pedersen, and M. Gardner, Replication of LAV, HTLV-III, and ARV-2, Journal of Interferon Research, vol.6, issue.2, pp.143-152, 1986.
DOI : 10.1089/jir.1986.6.143

G. Peng, K. Lei, J. W. Greenwell-wild, T. Wahl, and S. , Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti???HIV-1 activity, The Journal of Experimental Medicine, vol.13, issue.1, pp.41-46, 2006.
DOI : 10.1006/meth.2001.1262

G. Mangino, Z. Percario, G. Fiorucci, G. Vaccari, S. Manrique et al., In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I??B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon, Journal of Virology, vol.81, issue.6, pp.2777-2791, 2007.
DOI : 10.1128/JVI.01640-06

J. Fakruddin, R. Lempicki, R. Gorelick, J. Yang, J. Adelsberger et al., Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27, Blood, vol.109, issue.5, pp.1841-1849, 2007.
DOI : 10.1182/blood-2006-02-001578

T. Imamichi, Y. J. Huang, D. Brann, T. Fullmer, B. Adelsberger et al., IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages, AIDS, vol.22, issue.1, pp.39-45, 2008.
DOI : 10.1097/QAD.0b013e3282f3356c

T. Greenwell-wild, N. Vazquez, J. W. Rangel, Z. Munson, P. Wahl et al., Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon, Blood, vol.114, issue.9, pp.1864-1874, 2009.
DOI : 10.1182/blood-2009-03-211540

R. Harty, P. Pitha, and A. Okumura, Antiviral Activity of Innate Immune Protein ISG15, Journal of Innate Immunity, vol.1, issue.5, pp.397-404, 2009.
DOI : 10.1159/000226245

A. Okumura, G. Lu, I. Pitha-rowe, and P. Pitha, Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15, Proceedings of the National Academy of Sciences, vol.103, issue.5, pp.1440-1445, 2006.
DOI : 10.1073/pnas.0510518103

S. Wahl, T. Greenwell-wild, and N. Vazquez, HIV accomplices and adversaries in macrophage infection, Journal of Leukocyte Biology, vol.80, issue.5, pp.973-983, 2006.
DOI : 10.1189/jlb.0306130

L. Espert, G. Degols, Y. Lin, T. Vincent, M. Benkirane et al., Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1, Journal of General Virology, vol.86, issue.8, pp.2221-2229, 2005.
DOI : 10.1099/vir.0.81074-0

S. Barr, J. Smiley, and F. Bushman, The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22, PLoS Pathogens, vol.272, issue.2, p.1000007, 2008.
DOI : 10.1371/journal.ppat.1000007.s001

J. Lazdins, T. Klimkait, K. Woods-cook, M. Walker, E. Alteri et al., In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes, J Immunol, vol.147, pp.1201-1207, 1991.

I. Kamga, S. Kahi, L. Develioglu, M. Lichtner, C. Maranon et al., Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV???1 Infection, The Journal of Infectious Diseases, vol.192, issue.2, pp.303-310, 2005.
DOI : 10.1086/430931

G. Herbein and K. Khan, Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol, pp.61-67, 2008.

P. Aukrust, N. Liabakk, F. Muller, L. E. Espevik, T. Froland et al., Serum Levels of Tumor Necrosis Factor-?? (TNF??) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters, Journal of Infectious Diseases, vol.169, issue.2, pp.420-424, 1994.
DOI : 10.1093/infdis/169.2.420

G. Jacquot, L. Rouzic, E. David, A. Mazzolini, J. Bouchet et al., Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages, Retrovirology, vol.4, issue.1, p.84, 2007.
DOI : 10.1186/1742-4690-4-84

E. Kilareski, S. Shah, M. Nonnemacher, and B. Wigdahl, Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage, Retrovirology, vol.6, issue.1, p.118, 2009.
DOI : 10.1186/1742-4690-6-118

J. Herbeuval, J. Nilsson, A. Boasso, A. Hardy, M. Kruhlak et al., Differential expression of IFN-?? and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7000-7005, 2006.
DOI : 10.1073/pnas.0600363103

J. Meyers, J. Justement, C. Hallahan, E. Blair, Y. Sun et al., Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells, PLoS ONE, vol.84, issue.5, p.458, 2007.
DOI : 10.1371/journal.pone.0000458.s001

K. Nelms, A. Keegan, J. Zamorano, J. Ryan, and W. Paul, THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic Functions, Annual Review of Immunology, vol.17, issue.1, pp.701-738, 1999.
DOI : 10.1146/annurev.immunol.17.1.701

E. Papasavvas, J. Sun, Q. Luo, E. Moore, B. Thiel et al., IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes, The Journal of Immunology, vol.175, issue.8, pp.5532-5540, 2005.
DOI : 10.4049/jimmunol.175.8.5532

M. Benoit, B. Desnues, and J. Mege, Macrophage Polarization in Bacterial Infections, The Journal of Immunology, vol.181, issue.6, pp.3733-3739, 2008.
DOI : 10.4049/jimmunol.181.6.3733

O. Goldmann, V. Kockritz-blickwede, M. Holtje, C. Chhatwal, G. Geffers et al., Transcriptome Analysis of Murine Macrophages in Response to Infection with Streptococcus pyogenes Reveals an Unusual Activation Program, Infection and Immunity, vol.75, issue.8, pp.4148-4157, 2007.
DOI : 10.1128/IAI.00181-07

U. Mahlknecht and G. Herbein, Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?, Trends in Immunology, vol.22, issue.5, pp.256-260, 2001.
DOI : 10.1016/S1471-4906(01)01898-1

A. Varin, S. Mukhopadhyay, G. Herbein, and S. Gordon, Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion, Blood, vol.115, issue.2, pp.353-62, 2009.
DOI : 10.1182/blood-2009-08-236711

URL : https://hal.archives-ouvertes.fr/hal-00474829

G. Herbein, U. Mahlknecht, F. Batliwalla, P. Gregersen, T. Pappas et al., Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4, Nature, vol.395, pp.189-194, 1998.

C. Ogden, J. Pound, B. Batth, S. Owens, I. Johannessen et al., Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt's Lymphoma, The Journal of Immunology, vol.174, issue.5, pp.3015-3023, 2005.
DOI : 10.4049/jimmunol.174.5.3015

A. Byrne and D. Reen, Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils, The Journal of Immunology, vol.168, issue.4, pp.1968-1977, 2002.
DOI : 10.4049/jimmunol.168.4.1968

M. Clerici and G. Shearer, A TH1???TH2 switch is a critical step in the etiology of HIV infection, Immunology Today, vol.14, issue.3, pp.107-111, 1993.
DOI : 10.1016/0167-5699(93)90208-3

T. Oleksyk, S. Shrestha, A. Truelove, J. Goedert, S. Donfield et al., Extended IL10 haplotypes and their association with HIV progression to AIDS, Genes and Immunity, vol.32, issue.4, pp.309-322, 2009.
DOI : 10.1002/gepi.20037

A. Vasilescu, S. Heath, R. Ivanova, H. Hendel, H. Do et al., Genomic analysis of Th1???Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression, Genes and Immunity, vol.4, issue.6, pp.441-449, 2003.
DOI : 10.1038/sj.gene.6363983

O. Sandanger, L. Ryan, J. Bohnhorst, A. Iversen, H. Husebye et al., IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients, The Journal of Immunology, vol.182, issue.1, pp.588-595, 2009.
DOI : 10.4049/jimmunol.182.1.588

D. Creery, J. Angel, S. Aucoin, W. Weiss, W. Cameron et al., Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10, Clinical and Vaccine Immunology, vol.9, issue.6, pp.1212-1221, 2002.
DOI : 10.1128/CDLI.9.6.1212-1221.2002

R. Andrade, P. Lima, R. Filho, J. Hygino, S. Milczanowski et al., Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor ?? production, AIDS, vol.21, issue.13, pp.1763-1770, 2007.
DOI : 10.1097/QAD.0b013e3282ca83fa

D. Brooks, S. Ha, H. Elsaesser, A. Sharpe, G. Freeman et al., IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection, Proceedings of the National Academy of Sciences, vol.105, issue.51, pp.20428-20433, 2008.
DOI : 10.1073/pnas.0811139106

S. Gupta, R. Boppana, G. Mishra, B. Saha, and M. D. , HIV-1 Tat Suppresses gp120-Specific T Cell Response in IL-10-Dependent Manner, The Journal of Immunology, vol.180, issue.1, pp.79-88, 2008.
DOI : 10.4049/jimmunol.180.1.79

L. Fantuzzi, F. Belardelli, and S. Gessani, Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis, Journal of Leukocyte Biology, vol.74, issue.5, pp.719-725, 2003.
DOI : 10.1189/jlb.0403175

J. Rajasingh, E. Bord, C. Luedemann, J. Asai, H. Hamada et al., IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression, The FASEB Journal, vol.20, issue.12, pp.2112-2114, 2006.
DOI : 10.1096/fj.06-6084fje

Y. Wang and A. Rice, Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis, Virology, vol.352, issue.2, pp.485-492, 2006.
DOI : 10.1016/j.virol.2006.05.013

J. Brenchley, T. Schacker, L. Ruff, D. Price, J. Taylor et al., T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract, The Journal of Experimental Medicine, vol.72, issue.6, pp.749-759, 2004.
DOI : 10.4049/jimmunol.167.12.6711

M. Guadalupe, E. Reay, S. Sankaran, T. Prindiville, J. Flamm et al., Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy, Journal of Virology, vol.77, issue.21, pp.11708-11717, 2003.
DOI : 10.1128/JVI.77.21.11708-11717.2003

M. Guadalupe, S. Sankaran, M. George, E. Reay, D. Verhoeven et al., Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection, Journal of Virology, vol.80, issue.16, pp.8236-8247, 2006.
DOI : 10.1128/JVI.00120-06

Q. Li, L. Duan, J. Estes, Z. Ma, T. Rourke et al., Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, vol.139, pp.1148-1152, 2005.
DOI : 10.1038/nm0703-847

J. Mattapallil, D. Douek, B. Hill, Y. Nishimura, M. Martin et al., Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, vol.82, issue.7037, pp.1093-1097, 2005.
DOI : 10.1084/jem.164.1.280

S. Mehandru, M. Poles, K. Tenner-racz, A. Horowitz, A. Hurley et al., T Lymphocytes from Effector Sites in the Gastrointestinal Tract, The Journal of Experimental Medicine, vol.73, issue.6, pp.761-770, 2004.
DOI : 10.1038/nm833

S. Mehandru, M. Poles, K. Tenner-racz, V. Manuelli, P. Jean-pierre et al., Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.81, issue.2, pp.599-612, 2007.
DOI : 10.1128/JVI.01739-06

Z. Smit-mcbride, J. Mattapallil, M. Mcchesney, D. Ferrick, and S. Dandekar, Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes, J Virol, vol.72, pp.6646-6656, 1998.

R. Veazey, M. Demaria, L. Chalifoux, D. Shvetz, D. Pauley et al., Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection, Science, vol.280, issue.5362, pp.427-431, 1998.
DOI : 10.1126/science.280.5362.427

L. Li, G. Meng, M. Graham, G. Shaw, and P. Smith, Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5, Gastroenterology, vol.116, issue.5, pp.1043-1053, 1999.
DOI : 10.1016/S0016-5085(99)70007-7

G. Meng, M. Sellers, M. Mosteller-barnum, T. Rogers, G. Shaw et al., Lamina Propria Lymphocytes, Not Macrophages, Express CCR5 and CXCR4 and Are the Likely Target Cell for Human Immunodeficiency Virus Type 1 in the Intestinal Mucosa, The Journal of Infectious Diseases, vol.182, issue.3, pp.785-791, 2000.
DOI : 10.1086/315790

P. Gorry, G. Bristol, J. Zack, K. Ritola, R. Swanstrom et al., Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity, Journal of Virology, vol.75, issue.21, pp.10073-10089, 2001.
DOI : 10.1128/JVI.75.21.10073-10089.2001

P. Smith, L. Smythies, M. Mosteller-barnum, D. Sibley, M. Russell et al., Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities, The Journal of Immunology, vol.167, issue.5, pp.2651-2656, 2001.
DOI : 10.4049/jimmunol.167.5.2651

L. Smythies, M. Sellers, R. Clements, M. Mosteller-barnum, G. Meng et al., Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity, Journal of Clinical Investigation, vol.115, issue.1, pp.66-75, 2005.
DOI : 10.1172/JCI200519229

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539188/pdf

M. Schenk, A. Bouchon, S. Birrer, M. Colonna, and C. Mueller, Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine, The Journal of Immunology, vol.174, issue.1, pp.517-524, 2005.
DOI : 10.4049/jimmunol.174.1.517

M. Schenk, A. Bouchon, F. Seibold, and C. Mueller, TREM-1???expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases, Journal of Clinical Investigation, vol.117, issue.10, pp.3097-3106, 2007.
DOI : 10.1172/JCI30602DS1

J. Rugtveit, A. Bakka, and P. Brandtzaeg, Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD), Clinical and Experimental Immunology, vol.110, issue.1, pp.104-113, 1997.
DOI : 10.1111/j.1365-2249.1997.507-ce1404.x

P. Smith, G. Meng, J. Salazar-gonzalez, and G. Shaw, Macrophage HIV-1 infection and the gastrointestinal tract reservoir, Journal of Leukocyte Biology, vol.74, issue.5, pp.642-649, 2003.
DOI : 10.1189/jlb.0503219

P. Smith, C. Ochsenbauer-jambor, and L. Smythies, Intestinal macrophages: unique effector cells of the innate immune system, Immunological Reviews, vol.112, issue.1, pp.149-159, 2005.
DOI : 10.1126/science.1103685

R. Shen, H. Richter, R. Clements, L. Novak, K. Huff et al., Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.83, issue.7, pp.3258-3267, 2009.
DOI : 10.1128/JVI.01796-08

T. Fischer-smith, C. Bell, S. Croul, M. Lewis, and J. Rappaport, Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: Lessons from human and nonhuman primate studies, Journal of Neurovirology, vol.14, issue.4, pp.318-326, 2008.
DOI : 10.1080/13550280802132857

S. Koenig, H. Gendelman, J. Orenstein, D. Canto, M. Pezeshkpour et al., Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science, vol.233, issue.4768, pp.1089-1093, 1986.
DOI : 10.1126/science.3016903

M. Cherner, E. Masliah, R. Ellis, T. Marcotte, D. Moore et al., Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis, Neurology, vol.59, issue.10, pp.1563-1567, 2002.
DOI : 10.1212/01.WNL.0000034175.11956.79

G. Nuovo and M. Alfieri, AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines, Mol Med, vol.2, pp.358-366, 1996.

Y. Saito, L. Sharer, L. Epstein, J. Michaels, M. Mintz et al., Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues, Neurology, vol.44, issue.3, Part 1, pp.474-481, 1994.
DOI : 10.1212/WNL.44.3_Part_1.474

M. Ghafouri, S. Amini, K. Khalili, and B. Sawaya, HIV-1 associated dementia: symptoms and causes, Retrovirology, vol.3, issue.1, p.28, 2006.
DOI : 10.1186/1742-4690-3-28

L. Davis, B. Hjelle, V. Miller, D. Palmer, A. Llewellyn et al., Early viral brain invasion in iatrogenic human immunodeficiency virus infection, Neurology, vol.42, issue.9, pp.1736-1739, 1992.
DOI : 10.1212/WNL.42.9.1736

J. Niederkorn, See no evil, hear no evil, do no evil: the lessons of immune privilege, Nature Immunology, vol.420, issue.4, pp.354-359, 2006.
DOI : 10.1038/ni1328

M. Li, Y. Wan, S. Sanjabi, A. Robertson, and R. Flavell, TRANSFORMING GROWTH FACTOR-?? REGULATION OF IMMUNE RESPONSES, Annual Review of Immunology, vol.24, issue.1, pp.99-146, 2006.
DOI : 10.1146/annurev.immunol.24.021605.090737

D. Boche, C. Cunningham, J. Gauldie, and V. Perry, Transforming growth factorbeta 1-mediated neuroprotection against excitotoxic injury in vivo, J Cereb Blood Flow Metab, vol.23, pp.1174-1182, 2003.

Y. Persidsky and L. Poluektova, Immune privilege and HIV-1 persistence in the CNS, Immunological Reviews, vol.177, issue.1, pp.180-194, 2006.
DOI : 10.1189/jlb.0503205

P. Massa, Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides, Journal of Experimental Medicine, vol.178, issue.4, pp.1357-1363, 1993.
DOI : 10.1084/jem.178.4.1357

C. Achim, M. Morey, and C. Wiley, Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients, AIDS, vol.5, issue.5, pp.535-541, 1991.
DOI : 10.1097/00002030-199105000-00009

S. An, A. Ciardi, B. Giometto, T. Scaravilli, F. Gray et al., Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients, Acta Neuropathologica, vol.91, issue.5, pp.494-503, 1996.
DOI : 10.1007/s004010050457

Y. Persidsky, A. Ghorpade, J. Rasmussen, J. Limoges, X. Liu et al., Microglial and Astrocyte Chemokines Regulate Monocyte Migration through the Blood-Brain Barrier in Human Immunodeficiency Virus-1 Encephalitis, The American Journal of Pathology, vol.155, issue.5, pp.1599-1611, 1999.
DOI : 10.1016/S0002-9440(10)65476-4

T. Suter, G. Biollaz, D. Gatto, L. Bernasconi, T. Herren et al., The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation, European Journal of Immunology, vol.33, issue.11, pp.2998-3006, 2003.
DOI : 10.1002/eji.200323611

U. Fassnacht, A. Ackermann, P. Staeheli, and J. Hausmann, Immunization with dendritic cells can break immunological ignorance toward a persisting virus in the central nervous system and induce partial protection against intracerebral viral challenge, Journal of General Virology, vol.85, issue.8, pp.2379-2387, 2004.
DOI : 10.1099/vir.0.80115-0

A. Schwartz, X. Alvarez, and A. Lackner, Distribution and Immunophenotype of DC-SIGN-Expressing Cells in SIV-Infected and Uninfected Macaques, AIDS Research and Human Retroviruses, vol.18, issue.14, pp.1021-1029, 2002.
DOI : 10.1089/08892220260235380

F. Gray, M. Lescs, C. Keohane, F. Paraire, B. Marc et al., Early Brain Changes in HIV Infection, Journal of Neuropathology and Experimental Neurology, vol.51, issue.2, pp.177-185, 1992.
DOI : 10.1097/00005072-199203000-00007

R. Potula, L. Poluektova, B. Knipe, J. Chrastil, D. Heilman et al., Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis, Blood, vol.106, issue.7, pp.2382-2390, 2005.
DOI : 10.1182/blood-2005-04-1403

M. Mccrossan, M. Marsden, F. Carnie, S. Minnis, B. Hansoti et al., An immune control model for viral replication in the CNS during presymptomatic HIV infection, Brain, vol.129, issue.2, pp.503-516, 2006.
DOI : 10.1093/brain/awh695

F. Gray, F. Scaravilli, I. Everall, F. Chretien, S. An et al., Neuropathology of Early HIV-1 Infection, Brain Pathology, vol.19, issue.1, pp.1-15, 1996.
DOI : 10.1002/ana.410200316

L. Wingertsmann, F. Chretien, F. Authier, F. Paraire, M. Durigon et al., Central nervous system lesions in the early stages of HIV infection], Arch Anat Cytol Pathol, vol.45, pp.106-117, 1997.

N. Sacktor, M. Mcdermott, K. Marder, G. Schifitto, O. Selnes et al., HIV-associated cognitive impairment before and after the advent of combination therapy, Journal of Neurovirology, vol.8, issue.2, pp.136-142, 2002.
DOI : 10.1080/13550280290049615

T. Wang, N. Gong, J. Liu, I. Kadiu, S. Kraft-terry et al., Proteomic Modeling for HIV-1 Infected Microglia-Astrocyte Crosstalk, PLoS ONE, vol.180, issue.6, p.2507, 2008.
DOI : 10.1371/journal.pone.0002507.t002

URL : http://doi.org/10.1371/journal.pone.0002507

K. Takahashi, S. Wesselingh, D. Griffin, J. Mcarthur, R. Johnson et al., Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry, Annals of Neurology, vol.38, issue.6, pp.705-711, 1996.
DOI : 10.1002/ana.410390606

Z. Wang, O. Pekarskaya, M. Bencheikh, W. Chao, H. Gelbard et al., Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120, Virology, vol.312, issue.1, pp.60-73, 2003.
DOI : 10.1016/S0042-6822(03)00181-8

S. Fine, R. Angel, S. Perry, L. Epstein, J. Rothstein et al., Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia, J Biol Chem, vol.271, pp.15303-15306, 1996.

B. Zhou, Y. Liu, B. Kim, Y. Xiao, and J. He, Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes, Molecular and Cellular Neuroscience, vol.27, issue.3, pp.296-305, 2004.
DOI : 10.1016/j.mcn.2004.07.003

G. Garden, Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, vol.22, issue.2, pp.240-251, 2002.
DOI : 10.1002/glia.10155

J. Mcarthur, B. Brew, and A. Nath, Neurological complications of HIV infection, The Lancet Neurology, vol.4, issue.9, pp.543-555, 2005.
DOI : 10.1016/S1474-4422(05)70165-4

W. Tyor, J. Glass, J. Griffin, P. Becker, J. Mcarthur et al., Cytokine expression in the brain during the acquired immunodeficiency syndrome, Annals of Neurology, vol.2, issue.4, pp.349-360, 1992.
DOI : 10.1002/ana.410310402

S. Wesselingh, K. Takahashi, J. Glass, J. Mcarthur, J. Griffin et al., Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry, Journal of Neuroimmunology, vol.74, issue.1-2, pp.1-8, 1997.
DOI : 10.1016/S0165-5728(96)00160-9

H. Xing, T. Moritoyo, K. Mori, C. Sugimoto, F. Ono et al., Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus, Neuropathology, vol.6, issue.1, pp.13-19, 2009.
DOI : 10.1111/j.1440-1789.2008.00929.x

E. Cassol, L. Cassetta, C. Rizzi, M. Alfano, and G. Poli, M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms, The Journal of Immunology, vol.182, issue.10, pp.6237-6246, 2009.
DOI : 10.4049/jimmunol.0803447

A. Boasso, G. Shearer, and C. Chougnet, Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?, Journal of Internal Medicine, vol.371, issue.1, pp.78-96, 2009.
DOI : 10.1111/j.1365-2796.2008.02043.x